SUPERNUS PHARMACEUTICALS, INC. - 8-K Filing
Indivior Pharmaceuticals, Inc. completed its acquisition of Supernus Pharmaceuticals, Inc., renaming itself Supernus, Inc. (Items: 1.01 Entry into a Material Definitive Agreement, 2.01 Completion of Acquisition or Disposition of Assets, 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, 3.03 Material Modification to Rights of Security Holders)
Tickers: $SUPN